Trials / Unknown
UnknownNCT02942940
Conventional Follow-up Versus Mobile App For Post-Operative ACL Reconstruction Patients
Conventional Follow-up Versus Mobile App Home Monitoring For Post-Operative Anterior Cruciate Ligament (ACL) Reconstruction Patients: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- University of Toronto Orthopaedic Sports Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Background: Telemedicine is increasingly used to overcome distance between patients and physicians. Preliminary studies suggest that mobile app follow-up care for ACL reconstruction patients is feasible, can avert in-person follow-up care, and is cost-effective. Objective: To avert in-person follow-up through the use of a mobile app in the first six weeks after surgery. Methods: This will be a single-center, prospective randomized controlled trial Results: Data to be analyzed from 72 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mobile app | The mobile app follow-up group will have no planned in-person follow-up, however these visits will be replaced with surgical site examination via submitted photos, Visual Analogue Scale (VAS), and Quality of Recovery - 9 questionnaire (QoR-9) and limb specific recovery monitoring. All information is submitted with the mobile app (QoC Health Inc, Toronto). |
| OTHER | conventional in-person | Patients in the conventional follow-up group will have a planned clinic follow-up at 2 and 6 weeks post-operatively, which is the schedule currently used by our surgeons. At these scheduled follow-up visits, patients will be asked to complete the VAS to assess pain and the QoR-9 in addition to recovery questions about their operated extremity. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- Completion
- 2018-04-01
- First posted
- 2016-10-24
- Last updated
- 2016-10-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02942940. Inclusion in this directory is not an endorsement.